Literature DB >> 782968

Vaccination by non-parenteral routes: characteristics of immune response.

P L Ogra, Y Chiba, K R Beutner, A Morag.   

Abstract

Antibody and cell-mediated immune response in systemic and external mucosal sites was studied after natural or vaccine induced infections with rubella and mumps viruses. Natural rubella infection or immunization with RA27/3 rubella vaccine by intranasal and frequently by the subcutaneous route resulted in regular appearance of antibody response in the serum and respiratory tract and cellular immunity in circulating lymphocytes and tonsillar lymphoid tissue. Subcutaneous immunization with HPV-77 and Cendehill rubella vaccine resulted in antibody response in the serum with little or no response in the respiratory tract. A minimal cell-mediated immune response in systemic or respiratory lymphoid tissue was observed after such immunization. Intranasal immunization with HPV-77 frequently elicited a transient antibody and cell-mediated activity in the respiratory tract with no response in the serum and peripheral lymphocytes. Studies carried out with natural mumps infection or subcutaneous immunization with live attenuated mumps vaccine suggested that either route of infection may result in the development of antibody and cell-mediated immune responses in systemic sites as well as in the respiratory tract. These observations suggest that the immunologic outcome of immunization by non-parenteral route may be determined by the types of viral antigen employed, the nature of locally available immuno-competent tissue, the ability of mucosal site to capture an antigen or accept replication of live virus vaccines, and the degree of prior sensitization with the same antigen.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 782968

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  10 in total

Review 1.  Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.

Authors:  L Cárdenas; J D Clements
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

2.  Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues.

Authors:  C Czerkinsky; M W Russell; N Lycke; M Lindblad; J Holmgren
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

Review 3.  The common mucosal immune system and current strategies for induction of immune responses in external secretions.

Authors:  J Mestecky
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

4.  Liposomes containing anti-idiotypic antibodies: an oral vaccine to induce protective secretory immune responses specific for pathogens of mucosal surfaces.

Authors:  S Jackson; J Mestecky; N K Childers; S M Michalek
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

5.  Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigen-specific T cells in the genital tract.

Authors:  J U Igietseme; R G Rank
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

6.  Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.

Authors:  M Quiding; I Nordström; A Kilander; G Andersson; L A Hanson; J Holmgren; C Czerkinsky
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

7.  Effect of parenteral immunization on the intestinal immune response to Salmonella typhi Ty21a.

Authors:  B D Forrest; J T LaBrooy; C E Dearlove; D J Shearman
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

8.  Native and mutant forms of cholera toxin and heat-labile enterotoxin effectively enhance protective efficacy of live attenuated and heat-killed Shigella vaccines.

Authors:  A B Hartman; L L Van De Verg; M M Venkatesan
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

9.  A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.

Authors:  Yuexiu Zhang; Mijia Lu; K C Mahesh; Eunsoo Kim; Mohamed M Shamseldin; Chengjin Ye; Piyush Dravid; Michelle Chamblee; Jun-Gyu Park; Jesse M Hall; Sheetal Trivedi; Supranee Chaiwatpongsakorn; Adam D Kenny; Satyapramod Srinivasa Murthy; Himanshu Sharma; Xueya Liang; Jacob S Yount; Amit Kapoor; Luis Martinez-Sobrido; Purnima Dubey; Prosper N Boyaka; Mark E Peeples; Jianrong Li
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-27       Impact factor: 12.779

10.  Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.

Authors:  J Xu-Amano; H Kiyono; R J Jackson; H F Staats; K Fujihashi; P D Burrows; C O Elson; S Pillai; J R McGhee
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.